rs2090409

This variant is located in the LOC107987108 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

age at menarche

Allele A
OR 4.70
p 2.0e-33
N 87,802
Meta-analysisLarge GWAS
European
Allele A
OR 0.10
p 2.0e-9
N 17,510
Meta-analysisLarge GWAS
European

health trait

Allele C
OR 0.01
p 3.0e-33
N 405,979
Large GWAS
European

testosterone measurement

Allele C
OR 0.03
p 2.0e-21
N 178,782
Large GWAS
European
Allele C
OR 0.03
p 1.0e-17
N 243,951
Large GWAS
European, South Asian
Allele C
OR 0.12
p 8.0e-11
N 148,248
Major Consortium StudyLarge GWAS
European

forced expiratory volume

Allele C
OR 0.02
p 2.0e-17
N 373,397
Large GWAS
European

Research that mentions this SNP (1)

Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status
AssociationN=2,416Yu‐Ling Cen et al.(2013)· Molecular Carcinogenesis

A hospital-based case-control study in rural and urban India (1,204 cases; 1,212 controls) examined genetic and lifestyle risk factors for breast cancer. Four SNPs in FGFR2 (rs1219648, rs2420946, rs2981575, rs2981582) showed positive associations with breast cancer (ORs 1.32-1.47). Additional SNPs in obesity and metabolic genes (rs374748 in FBN2, rs2922763 in HNF4G, rs2116830 in KCNMA1, rs11121832 in MTHFR, rs16886165 in MAP3K1, rs11594610 in TCF7L2, rs2274459 in MLN) were associated with increased breast cancer risk. Waist-to-hip ratio ≥0.95 showed strong association (OR 3.78; 95% CI 2.92-4.89), and women living first 20 years in rural areas showed protective effect (OR 0.77).

Traits studied:Breast cancerBreast cancer riskER+/PR+ breast cancerER/PR negative breast cancerTriple negative breast cancer

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…